WJA
TTPH

Williams Jones & Associates’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Williams Jones & Associates’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-719
Closed -$67K – 422
2016
Q1 		$67K Sell
719
-305
-30% -$30.5K ﹤0.01% 336
2015
Q4 		$205K Sell
1,024
-870
-46% -$174K 0.01% 320
2015
Q3 		$283K Buy
+1,894
New +$1.39M 0.01% 288

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Williams Jones & Associates's TTPH Position: Q2 2016 in Review

Williams Jones & Associates sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 719 shares — an estimated $67K sold.

Williams Jones & Associates first reported a position in TTPH in Q3 2015 and held it in 3 quarters. The position peaked at $283K in Q3 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

  • Williams Jones & Associates reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Williams Jones & Associates sold 719 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $67K.
  • Williams Jones & Associates first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • Williams Jones & Associates's Tetraphase Pharmaceuticals, Inc. position peaked at $283K in Q3 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on Williams Jones & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.